Cardiac Arrest, Out-Of-Hospital
3
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket
On Market (2)
Approved therapies currently available
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
PfizerEpinephrine
StrykerLUCAS 2 Active Decompression 2
ZollAED 3 with Uni-padz
Clinical Trials (3)
Total enrollment: 4,011 patients across 3 trials
Epinephrine Dose: Optimal Versus Standard Evaluation Trial
Start: May 2023Est. completion: Dec 20283,790 patients
Phase 4Recruiting
BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study
Start: May 2021Est. completion: Jan 2024183 patients
N/ACompleted
AED 3 Post-Approval Study
Start: Mar 2021Est. completion: Feb 202938 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 4,011 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.